On the day of assay, the mannitol and sucrose (MAS) buffer (1) was prepared by diluting sterile-filtered MAS 3 in distilled water, resulting in a solution with the following final concentrations: 220 mM mannitol, 70 mM sucrose, 10 mM KH 2 PO 4 , 5 mM MgCl 2 , 2 mM HEPES, 1 mM EGTA and 0.2% w/v fatty-acid free BSA (3117057001) (pH 7.2), and warmed to 37 C
(2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
it helps reduce the risk of chronic diseases like cancer and heart disease
This senolytic approach offers a promising therapeutic strategy for restoring hair growth and overall scalp health in aging individuals (8)
Summary Keywords GLP 1, nausea & vomiting, obesity, semaglutide, side effect, tirzepatide Citation Alhazmi A and le Roux CW (2026) Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies